Jill U. Adams is a freelance science journalist based in Albany, New York. She covers health, mental health and biomedical research for such publications as The Transmitter, The Washington Post, Scientific American, Undark and The Scientist. She has a Ph.D. in pharmacology from Emory University in Atlanta, Georgia.
Jill Adams
Contributing writer
From this contributor
Insights on suicidality and autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 8 December.
Plumbing the link between anti-CASPR2 antibodies and autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 1 December.
Plumbing the link between anti-CASPR2 antibodies and autism; and more
By
Jill Adams
2 December 2025 | 1 min read
SHANK3 deficiency and behavior in mice; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 November.
SHANK3 deficiency and behavior in mice; and more
By
Jill Adams
25 November 2025 | 2 min read
Role of maternal factors in autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 17 November.
Teasing out mosaicism cell by cell; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 10 November.
Explore more from The Transmitter
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.
By
Katie Moisse
15 December 2025 | 7 min read
How basic neuroscience has paved the path to new drugs
A growing list of medications—such as zuranolone for postpartum depression, suzetrigine for pain, and the gepants class of migraine medicines—exist because of insights from basic research.
How basic neuroscience has paved the path to new drugs
A growing list of medications—such as zuranolone for postpartum depression, suzetrigine for pain, and the gepants class of migraine medicines—exist because of insights from basic research.
By
Alex Kwan
15 December 2025 | 6 min read
Dispute erupts over universal cortical brain-wave claim
The debate highlights opposing views on how the cortex transmits information.
Dispute erupts over universal cortical brain-wave claim
The debate highlights opposing views on how the cortex transmits information.
By
Claudia López Lloreda
12 December 2025 | 5 min read